tau imaging news will change few primary care workups directly. For most patients with memory concerns, high-accuracy blood tests remain the first step, with new tau PET reserved for unclear or intermediate results. Tau imaging means a brain PET scan that lights up tau tangles.
Tangles are twisted deposits of tau protein that build up inside brain cells in Alzheimer's disease. On Aug. 14, 2026, FDA approved a new tracer for this use, Lantheus Tauklarify, for adults with cognitive impairment evaluated for Alzheimer's, according to the FDA approval notice.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the new scan adds
- How accurate is it?
- Who should — and should not — get it?
- What to ask your primary care doctor
- Frequently Asked Questions
What the new scan adds
Tauklarify uses florquinitau F 18, also called MK-6240. It binds to tau tangles so trained readers can score a scan as positive or negative. Approval rested on two blinded-read studies totaling 617 participants, as reported by Practical Neurology. It joins a larger test menu. Tauklarify is now one of three approved tau PET tracers, alongside amyloid PET, spinal fluid, and blood tests for Alzheimer's diagnosis, according to ALZFORUM.
That choice matters because each test answers a different question. Amyloid tests show plaques. Spinal fluid and blood tests show chemical signs of disease. Tau PET shows where tangles sit and how far they spread. Doctors use that spread to judge stage and to separate Alzheimer's from other causes of confusion.
How accurate is it?
Readers agreed strongly on negative scans and less strongly on positive scans. Across readers, positive agreement ran 68% to 88% and negative agreement ran 93% to 99%, according to Healio's report on the approval data. That pattern means a negative scan is more reassuring than a positive scan is decisive. A positive read still needs clinical judgment, memory testing, and often amyloid results.
A scan alone neither confirms nor excludes tau pathology, per the product label. Earlier detection may improve with this tracer. In 682 paired scans, MK-6240 found medial-temporal tau in 15% of cognitively unimpaired amyloid-positive people versus 6% with standard flortaucipir, University of Pittsburgh researchers reported in The Lancet in May 2026. That finding applies to research detection, not to screening healthy patients.
Who should — and should not — get it?
Appropriate-use guidance stays narrow. Experts rate only 5 of 17 clinical situations as appropriate for tau PET. They warn against testing people without thinking problems, for gene risk alone, or for work, legal, or insurance reasons. The label also sets limits.
Safety and effectiveness are not established for non-Alzheimer tau disorders. Use is limited to Alzheimer's evaluation in adults with cognitive impairment. For primary care, blood p-tau217 works as triage. Current guidance and 2026 meeting data support blood testing first, with PET to clarify gray-zone results rather than for routine screening, according to MedicalXpress reporting on Boston University research. This path cuts wait time, cost, and travel for most families.
What to ask your primary care doctor
Start with symptoms, function, drugs, sleep, mood, and medical causes. Ask whether a blood test for Alzheimer's markers fits your case. Ask what an unclear result would change.
If referral is discussed, clarify the goal. Useful questions include whether amyloid status is already known, whether dementia stage is uncertain, and whether treatment choice depends on tau burden. Bring a family member who sees daily function, plus written examples of problems. Bring a list of symptoms, medicines, and family history to that visit.
- symptoms and timing: when lapses began and what daily tasks changed
- current list: medicines, alcohol, sleep apnea, depression, thyroid and B12 history
- prior tests: memory scores, MRI, blood p-tau217, amyloid PET or spinal fluid
- next-step plan: what a positive or negative tau scan would change
Frequently Asked Questions
Will my primary care doctor order tau PET at the first memory visit?
Usually not. Blood testing, exam, labs, and brain imaging come first, with PET saved for unclear cases.
Does a positive tau scan mean I have Alzheimer's dementia?
No. It shows tau tangle pathology. Diagnosis also needs symptoms, exam findings, and often amyloid results.
Does a negative scan rule out Alzheimer's?
Not alone. Negative agreement is high, but doctors still weigh symptoms and other tests before deciding.
You Might Also Like
- Tauklarify Imaging for Alzheimer’s Tau Tangles in 2026: Accuracy, Limits, and Evidence Gaps for Primary Care Patients
- PrecivityAD2 as an Adjunct to a 2026 Alzheimer’s Assessment: Accuracy, Limits, and Evidence Gaps for Primary Care Patients
- FDA’s 2026 PrecivityAD2 Alzheimer’s Blood Test Clearance: Accuracy, Limits, and Evidence Gaps for Primary Care Patients
